EHC Stock Recent News
EHC LATEST HEADLINES
It has been a turbulent start to the year for the healthcare industry, as concerns about major cuts to Medicare and Medicaid coincide with the impact of tariffs on supplies and many other variables. Nonetheless, healthcare stocks have fared well compared to the energy and information technology sectors.
Encompass Health (EHC) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Does Encompass Health (EHC) have what it takes to be a top stock pick for momentum investors? Let's find out.
The Company will award research-funding grants totaling up to $60,000 BIRMINGHAM, Ala. , May 2, 2025 /PRNewswire/ -- Encompass Health is pleased to announce the opening of its request for 2025 research grant applications due Sept.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
BIRMINGHAM, Ala. , May 1, 2025 /PRNewswire/ -- Encompass Health Corporation (NYSE: EHC) today announced that its board of directors has declared a quarterly cash dividend on its common stock of $0.17 per share, payable on July 15, 2025, to holders of record on July 1, 2025.
BIRMINGHAM, Ala. , April 28, 2025 /PRNewswire/ -- Encompass Health Corp. (NYSE: EHC) today announced it will participate in the BofA Securities 2025 Healthcare Conference, which is being held May 13-15, 2025.
EHC's Q1 results benefit on the back of discharge growth and expansion endeavors, partly offset by high operating costs. It currently expects 2025 adjusted EPS from continuing operations within $4.85-$5.10.
Encompass Health (EHC) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.